| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |